Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS5267

Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course

Analysis of DU145 prostate cancer cells treated with the CDK inhibitor R547 at 3 doses for up to 24 hours. R547 exerts an antiproliferative effect on various cell lines. Results compared with those from PBMCs (GDS5266) and HCT116 cells (GDS5268) to identify pharmacodynamic biomarkers for R547.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 3 agent, 4 dose, 4 time sets

Platform:: GPL570
Series:: GSE15392
45 Samples

Download data: CEL

DataSet

Accession:: GDS5267

ID:: 5267

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose...
Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Accession: GDS5267

GEO DataSets
Related DataSets for GEO Profiles (Select 119829591) (1)
GEO DataSets
Type 2 diabetes and role of hepatokines
Type 2 diabetes and role of hepatokines
Accession: GDS3883

GEO DataSets
Related DataSets for GEO Profiles (Select 71226686) (1)
GEO DataSets
txid199484[Organism:noexp] (3)
Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets